Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

261 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risk of hypoglycaemia with oral antidiabetic agents in patients with Type 2 diabetes.
Holstein A, Egberts EH. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2003 Oct;111(7):405-14. doi: 10.1055/s-2003-44287. Exp Clin Endocrinol Diabetes. 2003. PMID: 14614647 Review.
Postmortem Analysis of Vitreous Humor For Detection of Antemortem Disorders in Glucose Metabolism. An Old Method Revisited.
Holstein A, Titze U, Hess C. Holstein A, et al. Exp Clin Endocrinol Diabetes. 2020 Apr;128(4):239-243. doi: 10.1055/a-0752-0028. Epub 2018 Oct 19. Exp Clin Endocrinol Diabetes. 2020. PMID: 30340233
Oral antidiabetic agents: how much kidney disease can we tolerate?
Mayer C, Holstein A, Stumvoll M. Mayer C, et al. Among authors: holstein a. Expert Rev Endocrinol Metab. 2007 Jul;2(4):469-475. doi: 10.1586/17446651.2.4.469. Expert Rev Endocrinol Metab. 2007. PMID: 30290417
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Holstein A, et al. Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777. Expert Opin Drug Saf. 2010. PMID: 20553106
Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
Holstein A, Stege H, Kovacs P. Holstein A, et al. Expert Opin Drug Saf. 2010 Mar;9(2):225-31. doi: 10.1517/14740330903496402. Expert Opin Drug Saf. 2010. PMID: 20001763 Review.
Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions.
Holstein A, Beil W. Holstein A, et al. Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):225-41. doi: 10.1517/17425250902806424. Expert Opin Drug Metab Toxicol. 2009. PMID: 19331589 Review.
Clinical implications of hepatogenous diabetes in liver cirrhosis.
Holstein A, Hinze S, Thiessen E, Plaschke A, Egberts EH. Holstein A, et al. J Gastroenterol Hepatol. 2002 Jun;17(6):677-81. doi: 10.1046/j.1440-1746.2002.02755.x. J Gastroenterol Hepatol. 2002. PMID: 12100613
The Glu23Lys polymorphism in KCNJ11 and impaired hypoglycaemia awareness in patients with type 1 diabetes.
Holstein A, Plaschke A, Stumvoll M, Kovacs P. Holstein A, et al. J Hum Genet. 2005;50(10):530-533. doi: 10.1007/s10038-005-0288-y. Epub 2005 Sep 2. J Hum Genet. 2005. PMID: 16142506
Unusual neurological manifestation of severe digitoxin intoxication with bilateral ballism and visual hallucinations.
Holstein A, Hassan A, Patzer OM, Rohde M. Holstein A, et al. Aging Clin Exp Res. 2015 Jun;27(3):391-3. doi: 10.1007/s40520-014-0289-9. Epub 2014 Nov 13. Aging Clin Exp Res. 2015. PMID: 25391368 No abstract available.
Severe hypoglycemia due to possible interaction between glibenclamide and sorafenib in a patient with hepatocellular carcinoma.
Holstein A, Kovacs P, Beil W. Holstein A, et al. Curr Drug Saf. 2013 Apr;8(2):148-52. doi: 10.2174/15748863113089990027. Curr Drug Saf. 2013. PMID: 23845193
261 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback